PPV to Guide Fluid Management in the PICU (PPV)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02308371 |
|
Recruitment Status :
Completed
First Posted : December 4, 2014
Results First Posted : January 2, 2017
Last Update Posted : January 2, 2017
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Sepsis Systemic Inflammatory Response Syndrome | Device: Automated Pulse Pressure Variation | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 100 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Diagnostic |
| Official Title: | Automated Pulse Pressure Variation Guided Fluid Management in the Pediatric Intensive Care Setting |
| Study Start Date : | November 2014 |
| Actual Primary Completion Date : | May 2016 |
| Actual Study Completion Date : | June 2016 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Prospective
Patients in this arm will have fluid given based on standard clinical data (blood pressure, heart rate, lactate level, urine output) in addition to information provided by automated pulse pressure variation (PPV). PPV will be followed for first 48 hours after recruitment to the study. Fluid (normal saline, albumin 5%, hetastarch per the clinician preference) will be given in 5cc/kg increments for PPV> 13 (in addition to standard clinical data) until PPV < 13.
|
Device: Automated Pulse Pressure Variation
Based on standard of care, the physician will give fluid as needed based on standard clinical data (heart rate, central venous pressure if available, blood pressure, urine output, physical exam, lactate level) and pulse pressure variation. PPV should be elevated consistently greater than 15 minutes before giving fluid without other symptoms of patient instability (low blood pressure, elevated lactate, tachycardia). Pulse pressure variation will be followed for 48 hours.
Other Names:
|
|
No Intervention: Retrospective
Patients in this arm were previously admitted to the PICU and were given fluid based on standard clinical data. PPV was not used to guide therapy in this group of patients.
|
- Total Fluid (ml/kg/Day) Given [ Time Frame: First 48 hours after enrollment ]Total fluid (ml/kg/day) given during the first 48 hours of enrollment
- Total Fluid Bolused [ Time Frame: 48 hours after enrollment ]Total fluid bolused within 48 hours after enrollment.
- Number of Hours on Vasopressors [ Time Frame: From pediatric ICU admission to pediatric ICU discharge (up to 149 days) ]Hours that a subject remained intubated during pediatric intensive care admission during subject recruitment
- Number of Days on Ventilatory Support [ Time Frame: From pediatric ICU admission to pediatric ICU discharge (up to 149 days) ]Number of days subject was on ventilatory support (during time of subject enrollment) to the pediatric critical care unit. This included subjects that were intubated or was on a ventilator with a tracheotomy
- Number of Days in the PICU [ Time Frame: From pediatric ICU admission to pediatric ICU discharge (up to 149 days) ]Number of days for admission pediatric critical care unit (admission during which subject was enrolled into the study)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | up to 17 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Admission to the University of North Carolina pediatric critical care unit, includes all patients admitted to the pediatric critical care service as well as all post-operative patients.
- No limitations for age or gender.
- Patient requires standard mechanical ventilation.
- Patient has an arterial line in place.
Exclusion Criteria:
- Patient not mechanically ventilated.
- Patient does not have arterial line placed.
- Patient requires extracorporeal life support.
- Patient requires placement on high frequency oscillatory ventilation.
- Pulse pressure variation unable to be obtained on monitor.
- Patient has open chest.
- Patient has arrhythmias.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02308371
| United States, North Carolina | |
| University of North Carolina | |
| Chapel Hill, North Carolina, United States, 27514 | |
| Principal Investigator: | Melissa R Hines, MD | University of North Carolina | |
| Study Director: | Umesh Joashi, MD | University of North Carolina |
| Responsible Party: | University of North Carolina, Chapel Hill |
| ClinicalTrials.gov Identifier: | NCT02308371 |
| Other Study ID Numbers: |
14-2019 |
| First Posted: | December 4, 2014 Key Record Dates |
| Results First Posted: | January 2, 2017 |
| Last Update Posted: | January 2, 2017 |
| Last Verified: | June 2016 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
|
critically ill pediatric patients fluid resuscitation |
|
Systemic Inflammatory Response Syndrome Inflammation Pathologic Processes Shock |

